Stockreport

FDA approves weight loss drug Zepbound for sleep apnea [MSNBC.com]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, thedrugmaker Eli Lilly said [Read more]